Archive - June 2020
Ultragenyx and Kyowa Kirin Announce U.S. FDA Approval of Crysvita (burosumab) for the Treatment of Tumor-Induced Osteomalacia (TIO)
Gaza Refugee Camps To Be Monitored For 4 Months To Assess Public Health Needs
Sanofi plans €610m vaccines investment to raise pandemic readiness
New cancer blood test proves more sensitive than current diagnostic methods
Novartis nabs new FDA approvals for Ilaris and Cosentyx
Roche’s Tecentriq shows promise in early triple-negative breast cancer
MSD/Pfizer’s diabetes drug Steglatro hits goal in CV outcomes trial
Government authorises use of dexamethasone for COVID-19